⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NVO News
Novo-Nordisk A/S
Novo Nordisk A/S (NVO) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation
accessnewswire.com
NVO
U.S. Weight Loss Market Status & Forecast Report 2025-2026: GLP-1 Boom Triggers Major Industry Shift as Medicalized Programs Disrupt the $135 Billion Diet Market
globenewswire.com
WW
NX
HLF
SMPL
NVO
LLY
U.S. Weight Loss Market Status & Forecast Report 2025-2026: GLP-1 Boom Triggers Major Industry Shift as Medicalized Programs Disrupt the $135 Billion Diet Market
globenewswire.com
WW
HLF
NVO
LLY
Esperoct (Novo Nordisk) Market Research Report 2026: Epidemiology, Pipeline Analysis, Trends, Strategies, & Forecasts, 2020-2025, 2025-2030F, 2035F
globenewswire.com
NVO
Esperoct (Novo Nordisk) Market Research Report 2026: Epidemiology, Pipeline Analysis, Trends, Strategies, & Forecasts, 2020-2025, 2025-2030F, 2035F
globenewswire.com
NVO
Novonesis named a Great Employer to Work For in North Carolina
globenewswire.com
NVO
Novonesis named a Great Employer to Work For in North Carolina
globenewswire.com
NVO
Novonesis named a Great Employer to Work For in North Carolina
globenewswire.com
NVO
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Novo Nordisk A/S - NVO
accessnewswire.com
NVO
TMates GLP-1 Weight Loss Program Claims Evaluated: 2026 Consumer Research Report on Compounded Semaglutide, Tirzepatide, Telehealth Weight-Loss Access, Pricing, and Verification Considerations
globenewswire.com
NVO
LLY